Questioning questions about symptoms of benign prostatic hyperplasia

Size: px
Start display at page:

Download "Questioning questions about symptoms of benign prostatic hyperplasia"

Transcription

1 Family Practice Vol. 18, No. 3 Oxford University Press 2001 Printed in Great Britain Questioning questions about symptoms of benign prostatic hyperplasia Ejda Hassler, Ingvar Krakau, Lars Häggarth, Lars Norlén and Peter Ekman Hassler E, Krakau I, Häggarth L, Norlén L and Ekman P. Questioning questions about symptoms of benign prostatic hyperplasia. Family Practice 2001; 18: Objectives. Our aim was to conduct a survey about urinary symptoms and to find out if questioning patients about symptoms is helpful for the GP to make medical decisions concerning prostate problems among middle-aged men. Methods. Twelve hundred randomly chosen men aged years from the general population in north-west Stockholm, Sweden were sent a questionnaire consisting of symptom questions focusing on prostate problems based on the International Prostate Symptom Score (I-PSS). A subset of 120 respondents were asked to answer the same questions again and to participate in a urological examination including urodynamics and ultrasonography. The main outcome measures were the prevalence of urinary symptoms and the relationship between the symptom score and objective measures. Results. A response rate of 86% was obtained in the questionnaire study. Twenty-one per cent of the respondents stated that they had general problems related to urination. Among individual symptoms, post-void dribbling and a weak stream were most common. Among the men examined at the Urological Department, the average prostatic volume was found to be 40 cm 3. Three out of four were assessed to have infravesical obstruction. No correlation between subjective symptoms and objective measurements of either a statistical or clinical significance was found. Conclusions. Urinary symptoms are common among middle-aged men. Further, an enlarged prostate and/or infravesical obstruction is often found in the ageing man. Information obtained by asking prostate-specific symptom questions cannot, however, serve as the foundation for the GP to find those men whose problems would be solved by actions directed at the prostate. Keywords. Benign prostatic hyperplasia, epidemiology, questionnaire. Introduction Lower urinary tract symptoms affecting older men are loosely termed prostatism. 1,2 The symptom complex includes voiding symptoms such as weak urinary stream, abdominal straining, hesitancy, intermittency, feeling of incomplete bladder emptying and post-void dribble. In addition, storage symptoms such as frequency, nocturia, urgency, urge incontinence and, possibly, dysuria may be noted. Serious complications considered to be associated Received 28 January 2000; Revised 13 September 2000; Accepted 8 January Department of Internal Medicine and Department of Urology, Karolinska Hospital, Stockholm, Sweden. Correspondence to Dr E Hassler, Research Center of General Medicine, Karolinska Hospital, Borgmästarvillan, S Stockholm, Sweden. with bladder outlet obstruction are acute or chronic urinary tract infection, acute or chronic urinary retention with or without overflow incontinence, and acute or chronic renal failure. 2,3 Today, apart from surgery, pharmacological treatment alternatives to alleviate complaints caused by an enlarged prostate are widely available. Thus, it has become a major challenge to the GP to select those older men who would benefit from treatment. However, unlike patients usually treated in urological wards, men visiting their GP can be supposed to have less pronounced signs and symptoms. The foundation for a decision is fragile and the consequences for the patient of the introduction of unnecessary and possibly harmful diagnostic procedures or of taking medicines have to be taken into account. The aim of this study was to survey urinary symptoms among middle-aged men in the general population and relate these symptoms to urological findings. 328

2 Methods Questioning questions about symptoms of benign prostatic hyperplasia 329 The study was approved by the Karolinska Institute Ethics Committee. Epidemiological study A total of 1200 men, aged years, were chosen randomly from the population in the north-west part of Greater Stockholm, exclusively for this study. The men received an introductory letter in April 1996 and were asked to complete a questionnaire and return it in an enclosed pre-paid envelope. If no reply was received, two follow-up letters were sent after 3 and 5 weeks, respectively. The symptom questions (Table 1) were based on the International Prostate Symptom Score (I-PSS). 4 The wording of the items was elaborated to fit the general population and the questions were arranged so as to be easy to answer by a symptom-free man. 5 Apart from the 10 symptom questions about storage and voiding and one question about general problems due to urination, five more questions were asked. One of Question no. TABLE 1 Questions asked Wording of question and answer 1 Do you have urinary problems? Yes;; No (2) (If Yes, do you know why?) 3 How many times do you have to urinate during the day? Maximum 4 times; 5 8 times;; At least 9 times 4 How many times do you have to urinate during the night? 0 1 time; 2 3 times;; At least 4 times 5 Do you experience a strong need to urinate? 6 Does a dripping faucet give you a strong impulse to urinate? 7 Is your need to urinate so urgent that you cannot withhold it until you reach the toilet? 8 Do you experience dribbling when you thought urination had ended? 9 Do you experience having a weak urinary stream? 10 Do you feel that you do not empty your bladder completely when urinating? 11 Does it happen that you have to urinate again within 15 minutes? 12 Do you have to push and strain to begin urination? The dividing line between the answers indicating health and those indicating problems is shown by two bold semicolons. them was included as number 2 in the questionnaire and was directed at men admitting urinary complaints. They were asked for their own opinion about the causes of the problems experienced. Four other questions dealt with any previous medical contacts due to all urological symptoms. Clinical study As a postscript to the questionnaire, the respondent was asked to give all his telephone numbers if he was willing to accept a possible invitation to participate in a clinical study. A total of 940 declared a willingness to participate. The exclusion of men with uncompleted questionnaires and men suffering from insulin-treated diabetes, prostatic carcinoma, surgery of the prostate or neurological disorders left 890 subjects eligible. One hundred and twenty men, sampled to represent the entire continuum of scores, were invited for a urological examination at Karolinska Hospital. An algorithm assigning greater weight to questions on obstruction than to those on irritation was used to select subjects for the clinical investigation. The reason for weighting was that obstructive symptoms imply the risk of urinary retention. Thirty men scoring high and 30 scoring low on this algorithm, and answering the general question as expected, were chosen. Two other groups of 30 men each scoring high and low, respectively, but with contradictory answers to the symptom questions in relation to the introductory question: Do you have urinary problems? Yes; No, were also included since patients uncertain of the impact on their health of a body sensation are frequents visitors to their GP. A urodynamic examination (including residual volume measurement, cystometry and pressure flow measurements) was carried out and evaluated jointly by two of the authors (LH and LN). The equipment used was a Synectics PolyUro System with a double-lumen 8 French catheter introduced into the bladder through the urethra and a pressure meter in the rectum. The subject also had trans-rectal ultrasonography ( Leopard with probe type 8538 from B&K medical equipment). In cases of pathological findings, a referral to the routine medical service was made promptly. Ten symptom questions as well as a general question about urinary problems, with the same wording and in the same order as in the previous questionnaire, were included in a new questionnaire of 19 questions as items 5 and The other questions, not to be discussed in the present paper, dealt with possible medication and any difficulties caused by urinary problems in the respondent s personal life. Only one of the authors (EH, who did not participate in the urological examinations) knew the subjects scores on the two questionnaires. Statistical methods The software package SAS was used for the statistical analysis.

3 330 Family Practice an international journal Before the computations, the answers to the questions with three alternatives were transformed to four alternatives by replacing the middle alternative with a score of 2.5. Thus, the minimum total score on the symptom questions was zero and the maximum 30. Spearman rank correlation was used to describe the relationship between scores on the one hand and prostatic size and average urine flow on the other. The Kruskal Wallis test was used to compare average scores from those men with and without an obstruction. 6 Results The response rate to the epidemiological study was 86%. A total of 1001 men answered all 10 items about symptoms as well as the general question about urinary problems. A straightforward inspection of dichotomized data showed that post-void dribbling and a weak stream were the main symptoms. Analyses of dichotomized answers from men expressing concern about urinary symptoms and those neglecting general urinary problems, respectively, gave a similar outcome (Table 2). The correlation coefficient between total score and the answer to the question about general concern was Eighty-five men with no previous urological contacts or extra-urological conditions interfering with voiding came to the Urological Department. The median age of the subjects was 60 years. Their total score was , median The examinations took place between November and August , the time between answering the first and second questionnaire thus varying by between 6 and 13 months. The median time between filling in questionnaires was 10 months. All the men, apart from three, changed their answer to one or more questions. The answer to the question about post-void dribble was changed by 40 men; the other questions were more stable over time. The mean difference between the first and the second total score was zero. Nineteen men changed their opinion as to whether the symptoms were problematic or not. The median average urine flow for the subjects was 3.7 ml/second, ranging from 0.7 to 13 ml/second. The examining urologists assessed 64 men as having an obstruction from the urodynamic findings. Information on prostatic size was missing for one subject. The median volume of the prostate for the other 84 men was 40 cm 3, ranging from 11 to 103 cm 3. The correlation coefficients between the total score (according to the first questionnaire given) on the one hand, and prostatic volume and average urine flow on the other, were 0.14 and 0.18, respectively. No statistically significant difference in the total score for men judged as having an obstruction compared with those without was found (P = 0.87). Similar results were obtained when the second questionnaire was used. Discussion No clinically important relationships between the total score, prostate size, average urine flow and obstruction could be demonstrated. Thus, asking presumed prostatespecific questions such as those in the I-PSS is not a very selective way to identify older men in the general population suffering from significant prostate enlargement and/or infravesical obstruction. There is hardly any reason to believe that questions put verbally by the doctor would have been more selective. Probably there are no TABLE 2 Answers indicating urinary problems as a percentage and numbers of men with problems, distributed in accordance with their answer to the general question Item number and content Percentage of answers No. of men with problems, distributed indicating problems in accordance with their answer to the n = 1001 general question about urinary problems 1 General urinary problems 20.8 Yes (n = 208) No (n = 793) 8 Post-void dribbling Weak urinary stream Incomplete emptying Hesitancy Easily induced impulse Day-time frequency Urgency Rapidly repeated need Nocturia Urge incontinence

4 Questioning questions about symptoms of benign prostatic hyperplasia 331 specific prostate questions to be asked, since it has been shown that elderly women answer such questions in the same way as men do and obtain similar scores. 7 Other authors 4 8 have used receiver operating characteristic (ROC) curves to achieve a sense of confidence in the tests discriminative capacity. ROC curves describe cut off points as trade offs between sensitivity and specificity. A gold standard is needed when a cut off point has to be chosen. However, unfortunately, no gold standard for so-called clinically benign prostatic hyperplasia exists. Instead, a treatment decision can be the subject of negotiations between the doctor and the patient. We base this supposition on the report by Isaacs 9 which showed that the number of men with subjective problems and the number who were treated surgically was almost identical. The reported good outcomes of different actions on the prostate may be ascribed to placebo effects, which seem to be very common in prostatic treatment. 2,9 As shown in several studies, e.g , the type and frequency of individual symptoms change with ageing. Other studies have included participants from ~40 years of age with no upper limit. This makes comparisons of total scores and/or separate questions difficult, since the age spread in other studies means that the number of men of comparable age is very small. We chose men between 55 and 65 years of age for two reasons: (i) men younger than 55 years are seldom suspected of having prostate-associated lower urinary tract symptoms; and (ii) confounders to prostatic symptoms such as ageing mucous membranes and muscles, impaired nervous control of the bladder, etc. are more frequent among men over 65 years. Examining a sample of men from encounters at clinics or other places of care as in the study by Chute et al. 12 or Chai et al. 7 may underestimate the number of men without problems, the reverse of the healthy-worker effect. The exclusion of men with known problems may cut off the scores from the other end of the range. We used the census of all the inhabitants in the area, thus giving every man the same probability of being chosen, and we did not make any exclusions. In most studies, using symptom questions such as the I-PSS 4, the response rates reported were low. For example, a Dutch study 11 reported response rates of 33 35% for different age groups, and a French study conducted by Sagnier 14 showed similar figures. Given the high response rate for our questionnaire, the data can be claimed to be representative of the general population of urban middle-aged men. In this study, almost every second man had a prostate larger than 40 g, twice the size suggested by Garraway 13 as a lower boundary for prostatic enlargement, while three-quarters of all the men studied were judged to have an obstruction. Almost every second man thus fulfilled two of the three requirements for clinical action. 16 The subjective symptoms therefore seem to be decisive. However, since the subject s own perception of whether he is troubled by his symptoms varies considerably with time, medical decisions could not be based on the outcome of temporary questionnaires or questions. Watchful waiting instead of hasty prescribing of drugs based on the patient s complaints, and close co-operation between GPs and urologists would be a prudent strategy and, as Humphrey Bogart says at the end of the movie Casablanca This could be the beginning of a beautiful friendship. Conclusion Urinary symptoms are common among middle-aged men. Further, an enlarged prostate and/or infravesical obstruction is often found in the ageing man. Information obtained through a questionnaire similar to the I-PSS cannot, however, serve as the foundation for the GP to identify those men whose problems would be solved by actions directed at the prostate. Acknowledgements We want to thank Mrs Kerstin Cronwall RN, who skilfully took care of the urodynamic examinations at the Urological Department. Funding for this project was provided by Merck, Sharpe & Dohme. References 1 Abrams P. New words for old: lower urinary tract symptoms for prostatism. Br Med J 1994; 308: Nordling J, Hald T. BPH versus LUTS: reflections on lower urinary tract symptoms in search of a definition of clinical benign prostatic hyperplasia. Eur Urol Update Ser 1997; 6: Riehmann M, Hansen BJ, Polishuk PV, Nordling J, Hald T. Symptom scores in benign prostatic hyperplasia. Urology 1997; 49: Barry MJ, Fowler FJ, O Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis 1985; 38: Dawson-Saunders B, Trapp RG. Basic & Clinical Biostatistics. Norwalk, CT: Appleton & Lange, Chai TC, Belville WD, McGuire EJ, Nyquist L. Specificity of the AUA voiding symptom index: comparisons of unselected and selected samples of both sexes. J Urol 1993; 150: Hansen BJ, Flyger H, Brasso K et al. Validation of the selfadministered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol 1995; 76: Isaacs JT. Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention. Prostate Suppl 1990; 3: Sommer P, Nielsen KK, Bauer T et al. Voiding patterns in men evaluated by a questionnaire survey. Br J Urol 1990; 55: Bosch JL, Hop WC, Kirkels WJ, Schroeder FH. The International Prostate Symptom Score in a community-based sample of men

5 332 Family Practice an international journal between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995; 75: Chute CG, Panser LA, Girman CJ et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150: Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: Sagnier PP, MacFarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol 1994; 151: Malmsten U, Milsom I, Molander U, Norlén L. Urinary incontinence and lower urinary tract symptoms; an epidemiological study of men aged 45 to 99 years. J Urol 1997; 158: Roehrborn CG. Objective and subjective response criteria to diagnose benign prostatic hyperplasia. Eur Urol 1993; 24 (Suppl 1): 2 11.

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA American Urological Association symptom index for BPH RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, AND DISEASE-SPECIFIC QUALITY OF LIFE QUESTION IN PATIENTS WITH

More information

ISSN: (Print) (Online) Journal homepage:

ISSN: (Print) (Online) Journal homepage: Archives of Andrology Journal of Reproductive Systems ISSN: 0148-5016 (Print) (Online) Journal homepage: http://www.tandfonline.com/loi/iaan19 CHANGE IN INTERNATIONAL PROSTATE SYMPTOM SCORE AFTER TRANSURETHRAL

More information

A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM)

A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM) Malaysian Journal of Medical Sciences, Vol. 14, No. 2, July 2007 (67-71) SHORT COMMUNICATION A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL

More information

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal Original Article Intravesical Prostatic Protrusion is better than Prostate Volume in Predicting Symptom Severity in Benign Prostatic Hyperplasia: A Prospective Clinical Study Shrestha A, Chalise PR, Sharma

More information

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition

More information

INTERNATIONAL PROSTATE SYMPTOM SCORE IPSS - AUA AS DISCRIMINAT SCALE IN 400 MALE PATIENTS WITH LOWER URINARY TRACT SYMPTOMS (LUTS)

INTERNATIONAL PROSTATE SYMPTOM SCORE IPSS - AUA AS DISCRIMINAT SCALE IN 400 MALE PATIENTS WITH LOWER URINARY TRACT SYMPTOMS (LUTS) Urological Neurology International Braz J Urol Official Journal of the Brazilian Society of Urology IPSS IN MALE PATIENTS WITH LUTS Vol. 30 (2): 135-141, March - April, 2004 INTERNATIONAL PROSTATE SYMPTOM

More information

CHAPTER 6. M.D. Eckhardt, G.E.P.M. van Venrooij, T.A. Boon. hoofdstuk :49 Pagina 89

CHAPTER 6. M.D. Eckhardt, G.E.P.M. van Venrooij, T.A. Boon. hoofdstuk :49 Pagina 89 hoofdstuk 06 19-12-2001 09:49 Pagina 89 Urethral Resistance Factor (URA) Versus Schäfer s Obstruction Grade and Abrams-Griffiths (AG) Number in the Diagnosis of Obstructive Benign Prostatic Hyperplasia

More information

Trans Urethral Resection of Prostate (TURP)

Trans Urethral Resection of Prostate (TURP) Trans Urethral Resection of Prostate (TURP) Patient Information Author ID: SF Leaflet Number: Urol 010 Version: 6 Name of Leaflet: Trans Urethral Resection of Prostate (TURP) Date Produced: March 2018

More information

Benign Prostatic Hyperplasia (BPH):

Benign Prostatic Hyperplasia (BPH): Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate

More information

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,

More information

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of

More information

The Enlarged Prostate Symptoms, Diagnosis and Treatment

The Enlarged Prostate Symptoms, Diagnosis and Treatment The Enlarged Prostate Symptoms, Diagnosis and Treatment MAC00031-01 Rev G Financial support for this seminar has been provided by NeoTract, Inc., the manufacturer of the UroLift System. 1 Today s Agenda

More information

Patient Information. Lower Urinary Tract Symptoms (LUTS) and Diagnosis of BPE

Patient Information. Lower Urinary Tract Symptoms (LUTS) and Diagnosis of BPE Patient Information English 32 Lower Urinary Tract Symptoms (LUTS) and Diagnosis of BPE Symptoms The underlined terms are listed in the glossary. Benign prostatic enlargement (BPE) can affect the way you

More information

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size

More information

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms?

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms? PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS What is Benign Prostatic Hyperplasia (enlarged prostate)? Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate, the gland that

More information

Neurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder.

Neurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder. Definition: Neurogenic bladder Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder. Types: Nervous system diseases: Congenital: like myelodysplasia like meningocele.

More information

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,

More information

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin.

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin. The Professional Medical Journal DOI: 10.17957/TPMJ/17.4102 ORIGINAL PROF-4102 PROSTATIC HYPERPLASIA; COMPARISON BETWEEN TAMSULOSIN AND TERAZOSIN FOR EFFICACY IN MEDICAL MANAGEMENT OF LOWER URINARY TRACT

More information

The patient, your co-pilot in assessing LUTS

The patient, your co-pilot in assessing LUTS The patient, your co-pilot in assessing LUTS Frank Van der Aa Leuven, Belgium This symposium is supported by Astellas Pharma Europe Ltd., including speaker honoraria and production of materials the slides

More information

1088) had an IPSS of 8, indicating moderate-to- problem facing the growing number of elderly men in

1088) had an IPSS of 8, indicating moderate-to- problem facing the growing number of elderly men in BJU International (1999), 83, 410 415 Prevalence of lower urinary tract symptoms and self-reported diagnosed benign prostatic hyperplasia, and their evect on quality of life in a community-based survey

More information

Original Article. Introduction. Methods. Abstract

Original Article. Introduction. Methods. Abstract Blackwell Science, LtdOxford, UKIJUInternational Journal of Urology0919-81722003 Blackwell Publishing Asia Pty LtdNovember 20031011587594Original ArticleUsefulness of a1-blockers in BPHI Ikemoto et al.

More information

Dr. Aso Urinary Symptoms

Dr. Aso Urinary Symptoms Haematuria The presence of blood in the urine (haematuria) is always abnormal and may be the only indication of pathology in the urinary tract. False positive stick tests and the discolored urine caused

More information

Cooled ThermoTherapy TM

Cooled ThermoTherapy TM Are BPH Medications Weighing You Down? Think Outside the Pillbox Cooled ThermoTherapy TM A non-surgical, 30 minute in-office treatment that provides long-term relief from BPH symptoms and urinary obstruction

More information

All about the Prostate

All about the Prostate MEN S HEALTH Dr Nick Pendleton January 16 th 2018 All about the Prostate 1 What does it do? Functions of the Prostate 1. Secretes Prostatic Fluid slightly alkaline fluid, 30% of volume of seminal fluid,

More information

A unit of International Journal Foundation Page I 96

A unit of International Journal Foundation Page I 96 Occupational distribution of Patients with LUTS Single tertiary center experience. Part -4 (Medical Science) Chapter-III August/Vol.4.0/Issue-II ISSN NO : 2456-1045 ISSN CODE: 2456-1045 (Online) (ICV-MDS

More information

Trans urethral resection of prostate (TURP)

Trans urethral resection of prostate (TURP) Trans urethral resection of prostate (TURP) Information for patients Urology PROUD TO MAKE A DIFFERENCE SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST What is the prostate? Only men have a prostate

More information

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS DR. FRANCIS LEE Voiding dysfunction Storage Emptying Common voiding dysfunction in elderly male Emptying BPH Storage Incontinence Overactive bladder Post-prostatectomy

More information

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1 PATIENT INFORMATION BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have to be one of them! OVER 70% OF MEN IN THEIR 60s HAVE

More information

Prostate surgery. What is the prostate? What is a TURP? Why is a TURP operation necessary? Deciding to have a TURP operation.

Prostate surgery. What is the prostate? What is a TURP? Why is a TURP operation necessary? Deciding to have a TURP operation. What is the prostate? The prostate is a gland about the size of a walnut that is only present in men. It is located just below the bladder and surrounds the urethra, the tube through which urine flows

More information

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR Academic Sciences International Journal of Current Pharmaceutical Research ISSN- 0975-7066 Vol 5, Issue 1, 2013 Research Article COMPARISON OF THE EFFICACY AND SAFETY OF TAMSULOSIN (0.4 V/S (and) FINASTERIDE

More information

Experience the Innovative Therapy for Benign Prostate Enlargement

Experience the Innovative Therapy for Benign Prostate Enlargement Experience the Innovative Therapy for Benign Prostate Enlargement A Guide to Treatment of Benign Prostatic Hyperplasia 1. 2. The Prostate The prostate gland is a part of the male reproductive system. A

More information

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A PATIENT INFORMATION OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1 BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have

More information

Voiding Diary. Begin recording upon rising in the morning and continue for a full 24 hours.

Voiding Diary. Begin recording upon rising in the morning and continue for a full 24 hours. Urodvnamics Your physician has scheduled you for a test called URODYNAMICS. This test is a series of different measurements of bladder function and can be used to determine the cause of a variety of bladder

More information

Role of herbal drugs in the management of benign prostatic hyperplasia: Clinical trial to evaluate the efficacy and safety of Himplasia

Role of herbal drugs in the management of benign prostatic hyperplasia: Clinical trial to evaluate the efficacy and safety of Himplasia [Medicine Update (2003): 11(2), 55-58] Role of herbal drugs in the management of benign prostatic hyperplasia: Clinical trial to evaluate the efficacy and safety of Himplasia Arora, R.P., CMO, Rajiba L.

More information

BPH: a present and future perspective on health impact

BPH: a present and future perspective on health impact BPH: a present and future perspective on health impact Burden of disease in men with moderate LUTS Dalibor Pacík This presentation is financially supported by GlaxoSmithKline. CZ/DUTT/0019/12 Men with

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.06.02 Subject: Cialis Page: 1 of 5 Last Review Date: September 18, 2015 Cialis Description Cialis (tadalafil)

More information

INJINTERNATIONAL. Original Article INTRODUCTION

INJINTERNATIONAL. Original Article INTRODUCTION Official Journal of Korean Continence Society / Korean Society of Urological Research / The Korean Children s Continence and Enuresis Society / The Korean Association of Urogenital Tract Infection and

More information

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4.

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4. NIH Public Access Author Manuscript Published in final edited form as: J Urol. 2009 December ; 182(6): 2819 2824. doi:10.1016/j.juro.2009.08.086. Intravesical Prostatic Protrusion in Men in Olmsted County,

More information

Prevalence of Benign Prostatic Hyperplasia on Jeju Island: Analysis from a Cross-sectional Community-based Survey

Prevalence of Benign Prostatic Hyperplasia on Jeju Island: Analysis from a Cross-sectional Community-based Survey pissn: 2287-4208 / eissn: 2287-4690 World J Mens Health 2012 August 30(2): 131-137 http://dx.doi.org/10.5534/wjmh.2012.30.2.131 Original Article Prevalence of Benign Prostatic Hyperplasia on Jeju Island:

More information

Male LUTS, OAB, Sex: natural history. JR Sathiya

Male LUTS, OAB, Sex: natural history. JR Sathiya Male LUTS, OAB, Sex: natural history JR Sathiya Definitions Newer concepts of LUTs Natural history of BPH Prevalence of LUTs Definition BPH- represents a histologic diagnosis that refers to the proliferation

More information

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate NOTE: This policy is not effective until April 1, 2019. Medical Policy Manual Surgery, Policy No. 210 Transurethral Water Vapor Thermal Therapy of the Prostate Next Review: December 2019 Last Review: December

More information

P R E S E N T S Dr. Mufa T. Ghadiali is skilled in all aspects of General Surgery. His General Surgery Services include: General Surgery Advanced Laparoscopic Surgery Surgical Oncology Gastrointestinal

More information

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP Introduction to Enlarged Prostate E. David Crawford, MD Professor of Surgery (Urology) and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of

More information

Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service

Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service Mr. Tang, Chi Chiu Kevin (APN) Urology Center Department of Surgery Kwong Wah Hospital Redevelopment

More information

EXPERIMENTAL AND THERAPEUTIC MEDICINE 4: , 2012

EXPERIMENTAL AND THERAPEUTIC MEDICINE 4: , 2012 1112 Usefulness of total bladder capacity and post void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients SANG HYUB LEE, JOONG GEUN LEE, GYEONG

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.22 Subject: Cialis Page: 1 of 5 Last Review Date: September 15, 2017 Cialis Description Cialis (tadalafil)

More information

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI Page 1 Page 2 treatment of benign prostatic hyperplasia treatment of benign prostatic pdf treatment of benign prostatic

More information

Lower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME. Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan

Lower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME. Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan Lower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan 1 Definition of OAB Syndrome or symptom complex defined as urgency,

More information

AssociationbetweenSocieoeconomicVariablesSEVandBenignProstaticHyperplasiaBPHamongSudanesePatients

AssociationbetweenSocieoeconomicVariablesSEVandBenignProstaticHyperplasiaBPHamongSudanesePatients : I Surgeries and Cardiovascular System Volume 15 Issue 1 Version 1.0 Year 2015 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618

More information

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon Prostate case study Presented by Mr Alan Thompson Consultant Urological Surgeon 2 Part one Initial presentation A 62 year old male solicitor attends your GP surgery. He has rarely seen you over the last

More information

Urinary incontinence. Urology Department. Patient Information Leaflet

Urinary incontinence. Urology Department. Patient Information Leaflet Urinary incontinence Urology Department Patient Information Leaflet Introduction This leaflet is for people who have been diagnosed with urinary incontinence. It contains information about the bladder,

More information

The Neurogenic Bladder and Telemedicine: urologic history and physical exam development with a. Objectives

The Neurogenic Bladder and Telemedicine: urologic history and physical exam development with a. Objectives The Neurogenic Bladder and Telemedicine: urologic history and physical exam development with a movement towards home monitoring. Lynn Stothers, MD, MHSc, FRCSC Prof. Urology University of British Columbia

More information

Haldimand Physiotherapy Centre. Welcome Letter

Haldimand Physiotherapy Centre. Welcome Letter Haldimand Physiotherapy Centre 41 Caithness Street West, Caledonia, ON, N3W 2J2 Phone: (905)765-5449 email: ifeelgood@haldimandphysio.ca Website: www.haldimandphysio.ca Welcome Letter Welcome! Thank you

More information

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT Basrah Journal Of Surgery EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT MB, ChB, FIBMS, Assistant Professor

More information

EAU GUIDELINES POCKET EDITION 3

EAU GUIDELINES POCKET EDITION 3 EAU GUIDELINES POCKET EDITION 3 CONTENTS: BENIGN PROSTATIC HYPERPLASIA URINARY INCONTINENCE UROLITHIASIS 2 3 EAU POCKET GUIDELINES POCKET EDITION 3 This is one of a series of convenient pocket size books

More information

Please complete this voiding diary and questionnaire. Bring both of them with you to your next appointment with your provider.

Please complete this voiding diary and questionnaire. Bring both of them with you to your next appointment with your provider. Please complete this voiding diary and questionnaire. Bring both of them with you to your next appointment with your provider. To begin the diary, please choose two days when you will be at home. The two

More information

At the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS?

At the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS? 1 What Is IBS? At the outset, we want to clear up some terminology issues. IBS is the abbreviation that doctors use for irritable bowel syndrome, often when they are talking about people with IBS. We will

More information

encathopedia Volume 6 ENLARGED PROSTATE AND THE BLADDER

encathopedia Volume 6 ENLARGED PROSTATE AND THE BLADDER encathopedia Volume 6 ENLARGED PROSTATE AND THE BLADDER Enlarged prostate (benign prostatic hyperplasia, BPH) The prostate is a male gland, located just below the bladder. As men age, the prostate can

More information

Overactive Bladder: Diagnosis and Approaches to Treatment

Overactive Bladder: Diagnosis and Approaches to Treatment Overactive Bladder: Diagnosis and Approaches to Treatment A Hidden Condition* Many Many patients self-manage by voiding frequently, reducing fluid intake, and wearing pads Nearly Nearly two-thirds thirds

More information

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA A Minimally Invasive Innovative Treatment What is the prostate? The prostate is an accessory organ of the male reproductive system.

More information

The Hallmarks of BPH Progression and Risk Factors

The Hallmarks of BPH Progression and Risk Factors European Urology Supplements European Urology Supplements 2 (23) 2 7 The Hallmarks of BPH Progression and Risk Factors M. Emberton * Institute of Urology and Nephrology, University College London, 48 Riding

More information

Diagnosis and Mangement of Nocturia in Adults

Diagnosis and Mangement of Nocturia in Adults Diagnosis and Mangement of Nocturia in Adults Christopher Chapple Professor of Urology Sheffield Teaching Hospitals University of Sheffield Sheffield Hallam University UK 23 rd October 2015 Terminology

More information

Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS

Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS OhioHealth, Columbus Ohio Disclosures I have nothing to disclose Objectives Describe the role of a pelvic floor therapist in

More information

The prostate can be affected by three conditions that may cause problems for men as they get older.

The prostate can be affected by three conditions that may cause problems for men as they get older. The Prostate Gland The Prostate gland specific to males only, located in the pelvis between the bladder and rectum. It is about the shape and size of a walnut or satsuma and gets bigger as you get older.

More information

Korean Urologist s View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey

Korean Urologist s View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey Original Article DOI 10.3349/ymj.2010.51.2.248 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 51(2):248-252, 2010 Korean Urologist s View of Practice Patterns in Diagnosis and Management of Benign Prostatic

More information

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5 BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG Beaconsfield Medical Practice, Brighton As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder

More information

VOIDING DYSFUNCTION IN MULTIPLE SCLEROSIS

VOIDING DYSFUNCTION IN MULTIPLE SCLEROSIS Urological Neurology Brazilian Journal of Urology Official Journal of the Brazilian Society of Urology Vol. 26 (3): 315-320, May - June, 2000 VOIDING DYSFUNCTION IN MULTIPLE SCLEROSIS CEYHUN OZYURT, ÇAG

More information

The Evaluation of Bladder Symptoms in Patients With Lumbar Compression Disorders Who Have Undergone Decompressive Surgery

The Evaluation of Bladder Symptoms in Patients With Lumbar Compression Disorders Who Have Undergone Decompressive Surgery The Evaluation of Bladder Symptoms in Patients With Lumbar Compression Disorders Who Have Undergone Decompressive Surgery SPINE Volume 35, Number 17, pp E849 E854 2010, Lippincott Williams & Wilkins Chun-Hao

More information

Incontinence: Risks, Causes and Care

Incontinence: Risks, Causes and Care Welcome To Incontinence: Risks, Causes and Care Presented by Kamal Masaki, MD Professor and Chair Department of Geriatric Medicine John A. Burns School of Medicine, UH Manoa September 5, 2018 10:00 11:00

More information

Office Management of Benign Prostatic Enlargement

Office Management of Benign Prostatic Enlargement Focus on CME at McGill University Office Management of Benign Prostatic Enlargement Symptomatic benign prostate enlargement is a common medical problem encountered in our aging society. Watchful waiting,

More information

The ICS BPH Study: the psychometric validity and reliability of the ICSmale questionnaire

The ICS BPH Study: the psychometric validity and reliability of the ICSmale questionnaire British Journal of Urology (1996), 77, 554 56 The ICS BPH Study: the psychometric validity and reliability of the ICSmale questionnaire J.L. DONOVAN*,P. ABRAMS, T.J. PETERS*, H.E. KAY*, J. REYNARD, C.

More information

Saving. Kidneys. Benign Prostate Disease

Saving. Kidneys. Benign Prostate Disease Saving Kidneys 9 Benign Prostate Disease This booklet will tell you more about the prostate gland. Its functions and benign hyperplasia have been defined in a simple way. Ways to prevent and treat this

More information

Canada Medtronic of Canada Ltd Kitimat Road Mississauga, Ontario L5N 1W3 Canada Tel Fax

Canada Medtronic of Canada Ltd Kitimat Road Mississauga, Ontario L5N 1W3 Canada Tel Fax What PATIENTS About TUNA Say Therapy TUNA THERAPY I would consider it to be a complete success. I have essentially no residual problems of any kind. I m back to the way I was before I ever had any symptoms

More information

Title of Research Thesis:

Title of Research Thesis: Eastern Michigan University By Fatai Osinowo Adviser s Name: Dr. Stephen Sonstein, PhD Title of Research Thesis: A sub-analyses from the Benign Prostatic Hyperplasia (BPH) Registry and Patient survey:

More information

Dichotomous Estimation of Prostate Volume: A Diagnostic Study of the Accuracy of the Digital Rectal Examination

Dichotomous Estimation of Prostate Volume: A Diagnostic Study of the Accuracy of the Digital Rectal Examination pissn: 2287-4208 / eissn: 2287-4690 World J Mens Health 2013 December 31(3): 220-225 http://dx.doi.org/10.5534/wjmh.2013.31.3.220 Original Article Dichotomous Estimation of Prostate Volume: A Diagnostic

More information

Impact of smoking on Lower Urinary Tract Symptoms (LUTS) - Single tertiary centre experience

Impact of smoking on Lower Urinary Tract Symptoms (LUTS) - Single tertiary centre experience International Journal of Scientific and Research Publications, Volume 6, Issue 5, May 2016 119 Impact of smoking on Lower Urinary Tract Symptoms (LUTS) - Single tertiary centre experience AUB Pethiyagoda

More information

Measurement Properties of the Malay Version of the Golombok-Rust Inventory of Marital State (GRIMS) Among Urological Patients.

Measurement Properties of the Malay Version of the Golombok-Rust Inventory of Marital State (GRIMS) Among Urological Patients. ORIGINAL PAPER Measurement Properties of the Malay Version of the Golombok-Rust Inventory of Marital State (GRIMS) Among Urological Patients. Quek Kia Fatt, Low Wah Yun, And Hassan Razack, Loh Chit Sin,

More information

Physicians are required to be scrupulously honest in their dealings with the College.

Physicians are required to be scrupulously honest in their dealings with the College. CENSURE: IC1902 DR. AARON MATTIS MELLON On September 19, 2014, in accordance with Section 47(1)(c) of The Medical Act, the Investigation Committee censured Dr. Mellon as a record of its disapproval of

More information

Management of LUTS. Simon Woodhams February 2012

Management of LUTS. Simon Woodhams February 2012 Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract

More information

Lower UrinaryTract Symptoms (LUTS) and Sexual Function in Both Sexes

Lower UrinaryTract Symptoms (LUTS) and Sexual Function in Both Sexes European Urology European Urology 46 (2004) 229 234 Lower UrinaryTract Symptoms (LUTS) and Sexual Function in Both Sexes Bjarne Lühr Hansen * Research Unit of General Practice, University of Southern Denmark,

More information

Can men with prostates sized 80 ml or larger be managed conservatively?

Can men with prostates sized 80 ml or larger be managed conservatively? Original Article - Lower Urinary Tract Dysfunction Investig Clin Urol 2017;58:359-364. pissn 2466-0493 eissn 2466-054X Can men with prostates sized 80 ml or larger be managed conservatively? Alvin Lee,

More information

Prostate Enlargement Reduction

Prostate Enlargement Reduction Executive Summary Prostate Enlargement Reduction Healthcare Supplement What is Prostate Enlargement? For most men, these nightly bathroom runs may be the first sign of an enlarged prostate. Other symptoms

More information

Physiology & Neurophysiology of lower U.T.

Physiology & Neurophysiology of lower U.T. Physiology & Neurophysiology of lower U.T. Classification of voiding dysfunction Evaluation of a child with voiding dysfunction Management Storage Ø Adequate volume of urine Ø At LOW pressure Ø With NO

More information

Policy for Prostatism/Lower Urinary Tract Symptoms in men

Policy for Prostatism/Lower Urinary Tract Symptoms in men NHS Halton Clinical Commissioning Group NHS Liverpool Clinical Commissioning Group NHS St Helens Clinical Commissioning Group NHS South Sefton Clinical Commissioning Group NHS Southport and Formby Clinical

More information

Treatment-seeking behaviour and stated preferences for prostatectomy in Spanish men with lower urinary tract symptoms

Treatment-seeking behaviour and stated preferences for prostatectomy in Spanish men with lower urinary tract symptoms British Journal of Urology (1997), 79, 742 748 Treatment-seeking behaviour and stated preferences for prostatectomy in Spanish men with lower urinary tract symptoms D.J.W. HUNTER and A. BERRA-UNAMUNO Central

More information

INVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE

INVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE INVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE Tadashi Hanail*, Seiji Matsumotol*, Nobutaka Shimizu, Hirotsugu Uemural

More information

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 6 Ver. II (Jun. 2015), PP 33-37 www.iosrjournals.org Prostate Gland Volume and Its Relationship

More information

Outcomes of Midurethral Slings in Women with Concomitant Preoperative Severe Lower Urinary Tract Voiding Symptoms

Outcomes of Midurethral Slings in Women with Concomitant Preoperative Severe Lower Urinary Tract Voiding Symptoms ORIGINAL RESEARCH The Ochsner Journal 15:223 227, 2015 Ó Academic Division of Ochsner Clinic Foundation Outcomes of Midurethral Slings in Women with Concomitant Preoperative Severe Lower Urinary Tract

More information

Treating BPH: Comparing Rezum UroLift and HoLEP

Treating BPH: Comparing Rezum UroLift and HoLEP Treating BPH: Comparing Rezum UroLift and HoLEP Scott M. Cheney MD Mayo Clinic Arizona 2018 MFMER slide-1 Welcome to AZ 2018 MFMER slide-2 Outline Background on BPH, Rezum, Urolift, HoLEP AUA Guideline

More information

Thickening of bladder wall in men

Thickening of bladder wall in men Thickening of bladder wall in men The Borg System is 100 % Thickening of bladder wall in men Bladder wall thickening causes are inflammation due to urinary tract infection, benign, non-cancerous tissue

More information

Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms

Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms Sexual Dysfunction and Infertility Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms Darab Mehraban, Gholam Hossein Naderi, Seyed Reza Yahyazadeh, Mahdi Amirchaghmaghi Introduction: Our

More information

Bladder Cancer Knowing the Risks and Warning Signs. Part II: Warning Signs

Bladder Cancer Knowing the Risks and Warning Signs. Part II: Warning Signs Bladder Cancer Knowing the Risks and Warning Signs Part II: Warning Signs May 8, 2018 Presented by: is the Director of Urologic Oncology at MedStar Washington Hospital Center and an Assistant Professor

More information

Lower Urinary Tract Infection (UTI) in Males

Lower Urinary Tract Infection (UTI) in Males Lower Urinary Tract Infection (UTI) in Males Clinical presentation For patients in care homes see UTI in adults where IV Antibiotics in the community may be appropriate (under development) History and

More information

Bladder dysfunction in ALD and AMN

Bladder dysfunction in ALD and AMN Bladder dysfunction in ALD and AMN Sara Simeoni, MD Department of Uro-Neurology National Hospital for Neurology and Neurosurgery Queen Square, London 10:15 Dr Sara Simeoni- Bladder issues for AMN patients

More information

The ICS- BPH Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction

The ICS- BPH Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction British Journal of Urology (1998), 82, 619 623 The ICS- BPH Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction J.M. REYNARD1, Q. YANG2, J.L. DONOVAN3,T.J. PETERS3, W. SCHAFER4,

More information

PHARMACEUTICALS ISSUE 2.0 APRIL 1996 FINASTERIDE: CLINICAL AND ECONOMIC IMPACTS

PHARMACEUTICALS ISSUE 2.0 APRIL 1996 FINASTERIDE: CLINICAL AND ECONOMIC IMPACTS TECHNOLOGY OVERVIEW: PHARMACEUTICALS ISSUE 2.0 APRIL 1996 FINASTERIDE: CLINICAL AND ECONOMIC IMPACTS prepared by Dr. Nicolaas Otten, Pharm D. Coordinator, Pharmaceutical Assessment, CCOHTA This overview

More information

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate Michael James Naslund, MD, MBA; Muta M. Issa, MD, MBA; Amy L. Grogg, PharmD; Michael T. Eaddy, PharmD, PhD; and Libby Black, PharmD

More information

Overactive bladder can result from one or more of the following causes:

Overactive bladder can result from one or more of the following causes: Overactive bladder can affect people of any age; however, it is more common in older people. Effective treatments are available and seeing your doctor for symptoms of overactive bladder often results in

More information